Literature DB >> 7964827

Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure.

J F Acheson1, W T Green, M D Sanders.   

Abstract

The records of all patients undergoing optic nerve sheath decompression for visual failure in chronic raised intracranial pressure performed over a 15 year period have been reviewed. The aim was to study the visual outcome and relation to any shunting procedures. Fourteen patients (20 eyes) were identified in whom follow up information of at least one year was available. Eleven patients had benign intracranial hypertension (idiopathic intracranial hypertension) and three had dural venous sinus occlusive disease. Eight patients had unilateral surgery and six had bilateral surgery. Visual acuity and fields either improved or stabilised in 17 out of 20 eyes and three deteriorated. Of the eight patients undergoing unilateral surgery, the other eye remained stable in seven and deteriorated in one. Four patients required optic nerve sheath decompression despite previous shunting or subtemporal decompression. Five patients required shunts or subtemporal decompression after optic nerve sheath decompression because of persistent headache in three cases and for uncontrolled visual failure in two cases. No patients lost vision as a direct consequence of surgery. It is concluded that optic nerve sheath decompression is a safe and important therapeutic option in the management of chronic raised intracranial pressure complicated by visual loss. Vision can be saved after shunt failure, and in other cases may be maintained without the need for a shunt. Shunts may still be required, however, after optic nerve sheath decompression, especially for persistent headache.

Entities:  

Mesh:

Year:  1994        PMID: 7964827      PMCID: PMC1073203          DOI: 10.1136/jnnp.57.11.1426

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri.

Authors:  R C Sergott; P J Savino; T M Bosley
Journal:  Arch Ophthalmol       Date:  1988-10

2.  Cerebrospinal fluid diversion procedures in pseudotumor cerebri.

Authors:  M L Rosenberg; J J Corbett; C Smith; J Goodwin; R Sergott; P Savino; N Schatz
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

Review 3.  Operative complications of optic nerve sheath decompression.

Authors:  J L Plotnik; G S Kosmorsky
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

4.  Optic nerve sheath decompression for pseudotumor cerebri.

Authors:  N D Brourman; T C Spoor; J M Ramocki
Journal:  Arch Ophthalmol       Date:  1988-10

5.  Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach.

Authors:  J J Corbett; J A Nerad; D T Tse; R L Anderson
Journal:  Arch Ophthalmol       Date:  1988-10

6.  Factors affecting visual loss in benign intracranial hypertension.

Authors:  J C Orcutt; N G Page; M D Sanders
Journal:  Ophthalmology       Date:  1984-11       Impact factor: 12.079

  6 in total
  12 in total

1.  Idiopathic Intracranial Hypertension.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Effect of mitomycin C on the optic nerve in rabbits.

Authors:  H Mietz; T C Prager; C Schweitzer; J Patrinely; J R Valenzuela; R L Font
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

3.  Visual failure without headache in idiopathic intracranial hypertension.

Authors:  M Lim; M Kurian; A Penn; D Calver; J-P Lin
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

Review 4.  Papilledema: are we any nearer to a consensus on pathogenesis and treatment?

Authors:  Andrew G Lee; Michael Wall
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

5.  Idiopathic intracranial hypertension.

Authors:  Michael Wall
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

6.  Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension.

Authors:  S R Satti; L Leishangthem; M I Chaudry
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

Review 7.  Idiopathic intracranial hypertension (pseudotumor cerebri).

Authors:  Michael Wall
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

Review 8.  A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).

Authors:  Aristotelis Kalyvas; Eleftherios Neromyliotis; Christos Koutsarnakis; Spyridon Komaitis; Evangelos Drosos; Georgios P Skandalakis; Mantha Pantazi; Y Pierre Gobin; George Stranjalis; A Patsalides
Journal:  Neurosurg Rev       Date:  2020-04-25       Impact factor: 3.042

9.  Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995).

Authors:  J J Craig; D A Mulholland; J M Gibson
Journal:  Ulster Med J       Date:  2001-05

10.  Optic nerve sheath decompression for visual loss in intracranial hypertension: report from a tertiary care center in South India.

Authors:  Suneetha Nithyanandam; George J Manayath; Ravindra R Battu
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.